Log in or Sign up for Free to view tailored content for your specialty!
Dermatology News
Hooked on ID with Kathleen F. Gensheimer, MD, MPH, FIDSA
When I decided on a career in medicine, my passion was driven by a desire to serve.
Tattoo-related infections have risen sharply since 2000, study finds
HOUSTON — There has been a 77% increase in tattoo-related infections since 2000, a study found, although researchers say the number of infections is likely much higher.
Log in or Sign up for Free to view tailored content for your specialty!
Biden picks internal medicine physician Cohen to lead CDC
President Joe Biden on Friday officially announced that former North Carolina secretary of health Mandy K. Cohen, MD, MPH, will be the next director of the CDC.
Cutaneous granulomas associated with vaccine-derived and wild type rubella virus
Clinicians should consider rubella virus as a potential contributor to granulomatous skin disease in both immunodeficient and immunocompetent patients, according to a study.
Biden expected to name former NC health secretary as new CDC chief
President Joe Biden is set to announce former North Carolina secretary of health Mandy K. Cohen, MD, MPH, as the next director of the CDC, according to multiple reports.
Hooked on ID with Peter J. Hotez, MD, PhD, DSc, FASTMH, FAAP
I actually knew I wanted to study infectious diseases even before embarking on a career in medicine.
First US cases of tinea caused by T. indotineae reported in New York
Health officials identified the first cases of severe tinea, or ringworm, caused by Trichophyton indotineae in the U.S., according to case reports published in MMWR.
Hooked on ID with Rachael A. Lee, MD, MSPH
As the product of two hard-working academic physicians, I have never been without incredible examples of leaders in the field of medicine.
Tecovirimat may be preferred treatment for mpox
In the treatment of mpox, tecovirimat demonstrates superior toleration compared with other antivirals and may be the preferred treatment option for this disease, according to a study.
Lebrikizumab effective against moderate to severe atopic dermatitis, trials find
Two phase 3 trials found that lebrikizumab was effective against moderate-to-severe atopic dermatitis in adolescents and adults, researchers reported in The New England Journal of Medicine.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read